Trastuzumab, Pyrotinib Combined With Dalpiciclib and Endocrine Therapy for HR +/HER2 + Advanced Breast Cancer
Status: NOT_YET_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Neoplasm Female
Interventions: DRUG: Trastuzumab, Pyrotinib Combined With Dalpiciclib and Endocrine Therapy
Sponsor: Peking University Cancer Hospital & Institute